Abstract | OBJECTIVES: BACKGROUND: Effective treatment of patients with angina who have normal coronary arteriograms ( microvascular angina) has not yet been established. Rho-kinase-mediated calcium sensitization of the myosin light chain in smooth muscle cells has been implicated as substantially contributing to vascular hyperconstriction. METHODS: We studied consecutive 18 patients with angina and normal epicardial coronaries in whom intracoronary acetylcholine (ACh) induced myocardial ischemia (ischemic electrocardiographic changes, myocardial lactate production, or both) without angiographically demonstrable epicardial coronary vasospasm. All patients underwent a second ACh challenge test after pretreatment with either saline (n = 5) or fasudil (4.5 mg intracoronarily, n = 13). RESULTS:
Myocardial ischemia was reproducibly induced by ACh in the saline group. In contrast, 11 of the 13 patients pretreated with fasudil had no evidence of myocardial ischemia during the second infusion of ACh (p < 0.01). The lactate extraction ratio (median value [interquartile range]) during ACh infusion was improved by fasudil pretreatment, from -0.16 (-0.25 to 0.04) to 0.09 (0.05 to 0.18) (p = 0.0125). CONCLUSIONS:
|
Authors | Masahiro Mohri, Hiroaki Shimokawa, Yoji Hirakawa, Akihiro Masumoto, Akira Takeshita |
Journal | Journal of the American College of Cardiology
(J Am Coll Cardiol)
Vol. 41
Issue 1
Pg. 15-9
(Jan 01 2003)
ISSN: 0735-1097 [Print] United States |
PMID | 12570938
(Publication Type: Clinical Trial, Comparative Study, Controlled Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Cardiovascular Agents
- Enzyme Inhibitors
- Intracellular Signaling Peptides and Proteins
- Vasodilator Agents
- 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
- Protein Serine-Threonine Kinases
- rho-Associated Kinases
- Acetylcholine
- fasudil
|
Topics |
- 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
(administration & dosage, analogs & derivatives, therapeutic use)
- Acetylcholine
- Aged
- Cardiovascular Agents
- Coronary Circulation
(drug effects)
- Coronary Vasospasm
(complications, prevention & control)
- Enzyme Inhibitors
(administration & dosage, therapeutic use)
- Female
- Heart Function Tests
(methods)
- Humans
- Infusions, Intra-Arterial
- Intracellular Signaling Peptides and Proteins
- Microvascular Angina
(complications, prevention & control)
- Middle Aged
- Myocardial Ischemia
(etiology, prevention & control)
- Protein Serine-Threonine Kinases
(antagonists & inhibitors)
- Treatment Outcome
- Vasodilator Agents
(administration & dosage, therapeutic use)
- rho-Associated Kinases
|